Hyperlipoproteinemia, particularly Type IV, is strongly associated with extracranial and major intracranial atherosclerotic lesions rather than small-vessel disease in patients with cerebrovascular symptoms.
Answers are grounded in this paper and cite their sources.
Hyperlipoproteinemia may warrant targeted evaluation in large-vessel cerebrovascular disease; cross-sectional data leave open causality and practice implications.
The distribution of occlusive atherosclerotic lesions in the aortocranial circulation as determined by arteriography was correlated with results of plasma lipid and lipoprotein determinations of patients with symptoms and signs of cerebrovascular disease. The incidence of hyperlipoproteinemia in the total study population was 31.8%. The frequency of hyperlipoproteinemia was signigicantly higher in patients with atherosclerotic lesions limited to extracranial (51%) and intracranial major vessels (44.2%) when compared to the total number of patients and patients with only intracranial small-vessel disease (P less than .05). Type IV hyperlipoproteinemia was the most common abnormality (extracranial group, 42% type IV, 9% type II; intracranial major-vessel group, 35.8% type IV, 8.4% type II). Patients with intracranial small-vessel disease had the lowest frequency of hyperlipoproteinemia (14.2%). The frequency of hypertension with or without hyperlipoproteinemia was higher in patients with intracranial small-vessel disease (P less than .01).
No takes yet. Share an insight, caveat, or question.
Ninan T. Mathew (1975) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: